References
- Ashbury, F D.; Findlay, H.; Reynolds, B.; McKerracher, K. A Canadian survey of cancer patients' experiences: are their needs being met? J. Pain Symptom Manage. 1998, 16, 298–306. [PUBMED], [INFOTRIEVE], [CSA]
- Blesch, K S.; Paice, J A.; Wickham, R.; Harte, N.; Schnoor, D K.; Purl, S.; Rehwalt, M.; Kopp, P L.; Manson, S.; Coveny, S B.; McHale, M.; Cahill, M. Correlates of fatigue in people with breast or lung cancer. Oncol. Nurs. Forum 1991, 18, 81–87. [PUBMED], [INFOTRIEVE]
- Cella, D.; Davis, K.; Breitbart, W.; Curt, G. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J. Clin. Oncol. 2001, 19, 3385–3391. [PUBMED], [INFOTRIEVE]
- Curt, G A.; Breitbart, W.; Cella, D.; Groopman, J E.; Horning, S J.; Itri, L M.; Johnson, D H.; Miaskowski, C.; Scherr, S L.; Portenoy, R K.; Vogelzang, N J. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 2000, 5, 353–360. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hickok, J T.; Morrow, G R.; McDonald, S.; Bellg, A J. Frequency and correlates of fatigue in lung cancer patients receiving radiation therapy; implications for management. J. Pain Symptom Manage. 1996, 11, 370–377. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Irvine, D.; Vincent, L.; Graydon, J.; Bubela, N.; Thompson, L. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs. 1994, 17, 367–378. [PUBMED], [INFOTRIEVE], [CSA]
- Stone, P.; Hardy, J.; Broadley, K.; Tookman, A J.; Kurowska, A.; A'Hern, R. Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br. J. Cancer 1999, 79, 1479–1486. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vogelzang, N J.; Breitbart, W.; Cella, D.; Curt, G A.; Groopman, J E.; Horning, S J.; Itri, L M.; Johnson, D H.; Scherr, S L.; Portenoy, R K. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin. Hematol. 1997, 34 (Suppl. 2), 4–12. [PUBMED], [INFOTRIEVE], [CSA]
- Lesage, P.; Portenoy, R K. Management of fatigue in the cancer patient. Oncology 2002, 16, 373–378. [PUBMED], [INFOTRIEVE]
- Hamilton, J.; Butler, L.; Wagenaar, H.; Sveinson, T.; Ward, K A.; McLean, L.; Grant, D.; MacLellan, F. The impact and management of cancer-related fatigue on patients and families. Can. Oncol. Nurs. J. 2001, 11, 192–198. [PUBMED], [INFOTRIEVE], [CSA]
- National Institutes of Health. Symptom Management in Cancer: Pain, Depression, and Fatigue; National Institutes of Health State-of-the Science Conference Statement; July 15–17, 2002. Final statement: October 26, 2002.
- Gutstein, H B. The biological basis of fatigue. Cancer 2001, 92 (6 Suppl.), 1678–1683. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Andrykowski, M A.; Curran, S L.; Lightner, R. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J. Behav. Med. 1998, 21, 1–18., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Glaus, A.; Crow, R.; Hammond, S. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support. Care Cancer 1996, 4, 82–96. [PUBMED], [INFOTRIEVE], [CSA]
- Mock, V.; Atkinson, A.; Barsevick, A.; Cella, D.; Cimprich, B.; Cleeland, C.; Donnelly, J.; Eisenberger, M A.; Escalante, C.; Hinds, P.; Jacobsen, P B.; Kaldor, P.; Knight, S J.; Peterman, A.; Piper, B F.; Rug, H.; Sabbatini, P.; Stahl, C.; National Comprehensive Cancer Network. NCCN practice guidelines for cancer-related fatigue. Oncology (Huntingt.) 2000, 14, 151–161. [CSA]
- Rieger, P T. Assessment and epidemiologic issues related to fatigue. Cancer 2001, 15 (6 Suppl.), 1733–1736.
- Schwartz, A H. Validity of cancer-related fatigue instruments. Pharmacotherapy 2002, 22, 1433–1441. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Curtis, E B.; Krech, R.; Walsh, T D. Common symptoms in patients with advanced cancer. J. Palliat. Care 1991, 7, 25–29. [PUBMED], [INFOTRIEVE]
- Portenoy, R K.; Thaler, H T.; Kornblith, A B.; Lepore, J M.; Friedlander-Klar, H.; Coyle, N.; Smart-Curley, T.; Kemeny, N.; Norton, L.; Hoskins, W.; Scher, H. Symptom prevalence, characteristics and distress in a cancer population. Qual. Life Res. 1994, 3, 183–189. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wang, X S.; Giralt, S A.; Mendoza, T R.; Engstrom, M C.; Johnson, B A.; Peterson, N.; Broemeling, L D.; Cleeland, C S. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J. Clin. Oncol. 2002, 20, 1319–1328. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Broeckel, J A.; Jacobsen, P B.; Horton, J.; Balducci, L.; Lyman, G H. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 1998, 16, 1689–1696. [PUBMED], [INFOTRIEVE]
- Glaus, A. Fatigue–an orphan topic in patients with cancer?. Eur. J. Cancer 1998, 34, 1649–1651. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pater, J L.; Zee, B.; Palmer, M.; Johnston, D.; Osoba, D. Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30. Support. Care Cancer 1997, 5, 410–413. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Portenoy, R K.; Itri, L M. Cancer-related fatigue: guidelines for evaluation and management. Oncologist 1999, 4, 1–10. [PUBMED], [INFOTRIEVE], [CSA]
- Berger, A M. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol. Nurs. Forum 1998, 25, 51–62. [PUBMED], [INFOTRIEVE], [CSA]
- Malik, U R.; Makower, D F.; Wadler, S. Interferon-mediated fatigue. Cancer 2001, 92, 1664–1668. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Akechi, T.; Kugaya, A.; Okamura, H.; Yamawaki, S.; Uchitomi, Y. Fatigue and its associated factors in ambulatory cancer patients: a preliminary study. J. Pain Symptom Manage. 1999, 17, 42–48. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Andrews, P L.R.; Morrow, G R. Approaches to understanding the mechanisms involved in fatigue associated with cancer and its treatments: a speculative review. ESO Scientific Updates 2001, 5, 79–93. [CSA]
- Ancoli-Israel, S.; Moore, P J.; Jones, V. The relationship between fatigue and sleep in cancer patients: a review. Eur. J. Cancer Care 2001, 10, 245–255. [CSA], [CROSSREF]
- Stone, P.; Richards, M.; Hardy, J. Fatigue in patients with cancer. Eur. J. Cancer 1998, 34, 1670–1676. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Valentine, A D.; Meyers, C A. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer 2001, 92 (6 Suppl.), 1694–1698. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Visser, M R.; Smets, E M. Fatigue, depression and quality of life in cancer patients: how are they related?. Support. Care Cancer 1998, 6, 101–108. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Watanabe, S.; Bruera, E. Anorexia and cachexia, asthenia, and lethargy. Hematol. Oncol. Clin. North Am. 1996, 10, 189–206. [PUBMED], [INFOTRIEVE], [CSA]
- MacDonald, N.; Alexander, H R.; Bruera, E. Cachexia-anorexia-asthenia. J. Pain Symptom Manage. 1995, 10, 151–155. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- National Cancer Institute. PDQ Statement. Fatigue (PDQ®). Supportive Care-Health Professionals; Available at: http://cancernet.nci.nih.gov. Accessed February 19, 2004.
- Dimeo, F C. Effects of exercise on cancer-related fatigue. Cancer 2001, 92 (6 Suppl.), 1689–1693. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dimeo, F.; Stieglitz, R D.; Novelli-Fischer, U.; Fetscher, S.; Mertelsmann, R.; Keul, J. Correlation between physical performance and fatigue in cancer patients. Ann. Oncol. 1997, 8, 1251–1255. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Glaspy, J.; Bukowski, R.; Steinberg, D.; Taylor, C.; Tcheckmedyian, S.; Vadhan-Raj, S. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J. Clin. Oncol. 1997, 15, 1218–1234. [PUBMED], [INFOTRIEVE]
- Irvine, D M.; Vincent, L.; Bubela, N.; Thompson, L.; Graydon, J. A critical appraisal of the research literature investigating fatigue in the individual with cancer. Cancer Nurs. 1991, 14, 188–199. [PUBMED], [INFOTRIEVE]
- Stone, P.; Richards, M.; Hardy, J. Fatigue in patients with cancer. Eur. J. Cancer 1998, 34, 1670–1676. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Holzner, B.; Kemmler, G.; Greil, R.; Kopp, M.; Zeimet, A.; Raderer, M.; Hejna, M.; Zochbauer, S.; Krajnik, G.; Huber, H.; Fleischhacker, W W.; Sperner-Unterweger, B. The impact of hemoglobin levels on fatigue and quality of life in cancer patients. Ann. Oncol. 2002, 13, 965–973. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Touitou, Y.; Levi, F.; Bogdan, A.; Benavides, M.; Bailleul, F.; Misset, J L. Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors. J. Cancer Res. Clin. Oncol. 1995, 121, 181–188. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Berger, A M.; Farr, L. The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol. Nurs. Forum 1999, 26, 1663–1671. [PUBMED], [INFOTRIEVE], [CSA]
- Roscoe, J A.; Morrow, G R.; Hickok, J T.; Bushunow, P.; Matteson, S.; Rakita, D.; Andrews, P L. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support. Care Cancer 2002, 10, 329–336. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cella, D.; Peterman, A.; Passik, S.; Jacobsen, P.; Breitbart, W. Progress toward guidelines for the management of fatigue. Oncology (Huntingt) 1998, 12, 369–377. [CSA]
- Newell, S.; Sanson-Fisher, R W.; Girgis, A.; Bonaventura, A. How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer 1998, 83, 1640–1651. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Smets, E M.; Garssen, B.; Cull, A.; de Haes, J C. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br. J. Cancer 1996, 73, 241–245. [PUBMED], [INFOTRIEVE]
- Winstead-Fry, P. Psychometric assessment of four fatigue scales with a sample of rural cancer patients. J. Nurs. Meas. 1998, 6, 111–122. [PUBMED], [INFOTRIEVE], [CSA]
- Hann, D M.; Jacobsen, P B.; Azzarello, L M.; Martin, S C.; Curran, S L.; Fields, K K.; Greenberg, H.; Lyman, G. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual. Life Res. 1998, 7, 301–310. [PUBMED], [INFOTRIEVE], [CSA]
- Piper, B F.; Dibble, S L.; Dodd, M J.; Weiss, M C.; Slaughter, R E.; Paul, S M. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol. Nurs. Forum 1998, 25, 677–684. [PUBMED], [INFOTRIEVE], [CSA]
- Stein, K D.; Martin, S C.; Hann, D M.; Jacobsen, P B. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract. 1998, 6, 143–152. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yellen, S B.; Cella, D F.; Webster, K.; Blendowski, C.; Kaplan, E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J. Pain Symptom Manage. 1997, 13, 63–74. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schwartz, A L. The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol. Nurs. Forum 1998, 25, 711–717. [PUBMED], [INFOTRIEVE], [CSA]
- Morrow, G R.; Hickok, J T.; Roscoe, J A.; Raubertas, R F.; Andrews, P.; Flynn, P J.; Hynes, H E.; Banerjee, T K.; Kirshner, J J.; King, D K. The differential effects of paroxetine on fatigue and depression: a randomized, double blind trial from the University of Rochester CancerCenter Community Clinical Oncology Program. J. Clin. Oncol. 2003, 21, 4635–4641. [PUBMED], [INFOTRIEVE]
- McNair, D M.; Lorr, M.; Doppelman, L F. Profile of Mood States (POMS) Manual; Education and Industrial Testing Sevices: San Diego, 1971; 24–25.
- Jacobsen, P B.; Donovan, K A.; Weitzner, M A. Distinguishing fatigue and depression in patients with cancer. Semin. Clin. Neuropsychiatry 2003, 8, 229–240. [PUBMED], [INFOTRIEVE], [CSA]
- Stone, P.; Richardson, A.; Ream, E.; Smith, A G.; Kerr, D J.; Kearney, N. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Ann. Oncol. 2000, 11, 971–975. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Groopman, J E.; Itri, L M. Chemotherapy-induced anemia in adults: incidence and treatment. J. Natl. Cancer Inst. 1999, 91, 1616–1634. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Markham, A.; Bryson, H M. Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications. Drugs 1995, 49, 232–254. [PUBMED], [INFOTRIEVE]
- Demetri, G D.; Kris, M.; Wade, J.; Degos, L.; Cella, D. Quality-of-life benefit in chemotherapy patients treated with epoietin alfa is independent of disease response to tumor type: results from a prospective community oncology study. Procrit Study Group. J. Clin. Oncol. 1998, 16, 3412–3425. [PUBMED], [INFOTRIEVE]
- Gabrilove, J L.; Einhorn, L H.; Livingston, R B.; Winer, E.; Cleeland, C S. Once-weekly dosing of epoietin alfa is similar to three-times-weekly dosing in increasing hemoglobin and quality of life [abstract]. Proc. Am. Soc. Clin. Oncol. 1999, 18, 574
- Vansteenkiste, J.; Pirker, R.; Massuti, B.; Barata, F.; Font, A.; Fiegl, M.; Siena, S.; Gateley, J.; Tomita, D.; Colowick, A B.; Musil, J.; Aranesp 980297 Study Group. Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy. J. Natl. Cancer Inst. 2002, 94, 1211–1220. [PUBMED], [INFOTRIEVE]
- Littlewood, T J.; Bajetta, E.; Nortier, J W.; Vercammen, E.; Rapoport, B.; Epoetin Alfa Study Group. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J. Clin. Oncol. 2001, 19, 2865–2874. [PUBMED], [INFOTRIEVE]
- Osterborg, A.; Brandberg, Y.; Molostova, V.; Iosava, G.; Abdulkadyrov, K.; Hedenus, M.; Messinger, D.; Epoetin Beta Hematology Study Group. Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies. J. Clin. Oncol. 2002, 20, 2486–2494. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hedenus, M.; Adriansson, M.; SanMiguel, J.; Kramer, M H.; Schipperus, M R.; Juvonen, E.; Taylor, K.; Belch, A.; Altes, A.; Martinelli, G.; Watson, D.; Matcham, J.; Rossi, G.; Littlewood, T J.; Darbepoetin Alfa 20000161 Study Group. Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study. Br. J. Haematol. 2003, 122, 394–403. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Demetri, G D.; Gabrilove, J L.; Blasi, M V.; Hill, R J., Jr.; Glaspy, J. Benefits of epoetin alfa in anemic breast cancer patients receiving chemotherapy. Clin. Breast Cancer 2002, 3, 45–51. [PUBMED], [INFOTRIEVE], [CSA]
- Hotopf, M.; Chidgey, J.; Addington-Hall, J.; Ly, K L. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat. Med. 2002, 16, 81–97. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wellisch, D K.; Kaleita, T A.; Freeman, D.; Cloughesy, T.; Goldman, J. Predicting major depression in brain tumor patients. Psychooncology 2002, 11, 230–238. [PUBMED], [INFOTRIEVE]
- Ciaramella, A.; Poli, P. Assessment of depression among cancer patients: the role of pain, cancer type and treatment. Psychooncology 2001, 10, 156–165. [PUBMED], [INFOTRIEVE]
- Okamura, H.; Watanabe, T.; Narabayashi, M.; Katsumata, N.; Ando, M.; Adachi, I.; Akechi, T.; Uchitomi, Y. Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors. Breast Cancer Res. Treat. 2000, 61, 131–137. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Costantini, M.; Musso, M.; Viterbori, P.; Bonci, F.; Del Mastro, L.; Garrone, O.; Venturini, M.; Morasso, G. Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support. Care Cancer 1999, 7, 121–127. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Breitbart, W. Identifying patients at risk for, and treatment of major psychiatric complications of cancer. Support. Care Cancer 1995, 3, 45–60. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Morrow, G R.; Roscoe, J A.; Hickok, J T.; Smith, B.; Qazi, R. An SSRI antidepressant reduced depression but not fatigue in ninety-six breast cancer patients [abstract]. Support. Care Cancer 2001, 9, 319
- Radloff, L S. The CES-D scale: a self-report depressive scale for research in the general population. J. Appl. Psychol. Measure. 1977, 1, 385–401.
- Winningham, M L.; Nail, L M.; Burke, M B.; Brophy, L.; Cimprich, B.; Jones, L S.; Pickard-Holley, S.; Rhodes, V.; St Pierre, B.; Beck, S.; Glass, E C.; Mock, V L.; Mooney, K H.; Piper, B. Fatigue and the cancer experience: the state of the knowledge. Oncol. Nurs. Forum 1994, 21, 23–36. [PUBMED], [INFOTRIEVE], [CSA]
- Morrow, G R.; Hickok, J T.; Raubertas, R.; Flynn, P J.; Hynes, H E.; Banerjee, T K.; Kirshner, J J.; King, D K. Effect of an SSRI Antidepressant on Fatigue and Depression in Seven Hundred Thirty-Eight Cancer Patients Treated with Chemotherapy: A URCC CCOP Study. In abstract, Proceedings of the American Society of Clinical Oncology 2001 Annual Meeting, 2001; 1531
- Bruera, E.; Roca, E.; Cedaro, L.; Carraro, S.; Chacon, R. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat. Rep. 1985, 69, 751–754. [PUBMED], [INFOTRIEVE]
- Tannock, I.; Gospodarowicz, M.; Meakin, W.; Panzarella, T.; Stewart, L.; Rider, W. Treatment of metastatic prostatic cancer with low-dose prednisone; evaluation of pain and quality of life as pragmatic indices of response. J. Clin. Oncol. 1989, 7, 590–597. [PUBMED], [INFOTRIEVE]
- Cleare, A J.; Heap, E.; Malhi, G S.; Wessely, S.; O'Keane, V.; Miell, J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999, 353, 455–458. [PUBMED], [INFOTRIEVE], [CROSSREF]
- McKenzie, R.; O'Fallon, A.; Dale, J.; Demitrack, M.; Sharma, G.; Deloria, M.; Garcia-Borreguero, D.; Blackwelder, W.; Straus, S E. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 1998, 280, 1061–1066. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Burks, T F. New agents for the treatment of cancer-related fatigue. Cancer 2001, 15, 1714–1718. [CROSSREF]
- Olin, J.; Masand, P. Psychostimulants for depression in cancer patients. Psychosomatics 1996, 37, 57–62. [PUBMED], [INFOTRIEVE], [CSA]
- Weinshenker, B G.; Penman, M.; Bass, B.; Ebers, G C.; Rice, G P. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 1992, 42, 1468–1471. [PUBMED], [INFOTRIEVE]
- Krupp, L B.; Coyle, P K.; Doscher, C.; Miller, A.; Cross, A H.; Jandorf, L.; Halper, J.; Johnson, B.; Morgante, L.; Grimson, R. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 1995, 45, 1956–1961. [PUBMED], [INFOTRIEVE], [CSA]
- Broughton, R J.; Fleming, J A.E.; George, C F.P.; Hill, J D.; Kryger, M H.; Moldofsky, H.; Montplaisir, J Y.; Morehouse, R L.; Moscovitch, A.; Murphy, W F. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997, 49, 444–451. [PUBMED], [INFOTRIEVE], [CSA]
- US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann. Neurol. 1998, 43, 88–97. [CSA], [CROSSREF]
- US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 2000, 54, 1166–1175., [CSA]
- Adler, C H.; Caviness, J N.; Hentz, J G.; Lind, M.; Tiede, J. Effect of modafinil on excessive daytime sleepiness associated with Parkinson's disease. Sleep 2001, 24 (Suppl.), A368
- Happe, S.; Pirker, W.; Sauter, C.; Klosch, G.; Zeitlhofer, J. Successful treatment of excessive daytime sleepiness in Parkinson's disease with modafinil. J. Neurol. 2001, 248, 632–634. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pack, A I.; Black, J E.; Schwartz, J R.; Matheson, J K.; for the U.S. Modafinil in Obstructive Sleep Apnea Study Group. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 2001, 164, 1675–1681. [PUBMED], [INFOTRIEVE], [CSA]
- Rammohan, K W.; Rosenberg, J H.; Lynn, D J.; Blumenfeld, A M.; Pollak, C P.; Nagaraja, H N. Efficacy and safety of modafinil (Provigil®) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J. Neurol. Neurosurg. Psychiatry 2002, 72, 179–183. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zifko, U A.; Rupp, M.; Schwarz, S.; Zipko, H T.; Maida, E M. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. J. Neurol. 2002, 249, 983–987. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Menza, M A.; Kaufman, K R.; Castellanos, A M. Modafinil augmentation of antidepressant treatment of depression. J. Clin. Psychiatry 2000, 61, 378–381. [PUBMED], [INFOTRIEVE]
- DeBattista, C.; Lembke, A.; Solvason, H B.; Ghebremichael, R.; Poirier, J. A prospective trial of modafinil as an adjunctive treatment of major depression. J. Clin. Psychopharmacol. 2004, 24, 87–90. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cochran, J W. Effect of modafinil on fatigue associated with neurological illness. J. Chronic Fatigue Syndr. 2001, 8, 65–70. [CROSSREF]
- Beusterien, K M.; Rogers, A E.; Walsleben, J A.; Emsellem, H A.; Reblando, J A.; Wang, L.; Goswami, M.; Steinwald, B. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 1999, 22, 757–765. [PUBMED], [INFOTRIEVE], [CSA]
- Pigeau, R.; Naitoh, P.; Buguet, A.; McCann, C.; Baranski, J.; Taylor, M.; Thompson, M.; Mack, I. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J. Sleep Res. 1995, 4, 212–228. [PUBMED], [INFOTRIEVE]
- Rush, C R.; Kelly, T H.; Hays, L R.; Baker, R W.; Wooten, A F. Acute behavioral and physiological effects of modafinil in drug abusers. Behav. Pharmacol. 2002, 13, 105–115. [PUBMED], [INFOTRIEVE], [CSA]
- Jasinski, D R. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J. Psychopharmacol. 2000, 14, 53–60. [PUBMED], [INFOTRIEVE], [CSA]
- Duteil, J.; Rambert, F A.; Pessonnier, J.; Hermant, J F.; Gombert, R.; Assous, E. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur. J. Pharmacol. 1990, 180, 49–58. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Moldofsky, H.; Broughton, R J.; Hill, J D. A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy. Sleep Med. 2000, 1, 109–116. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dimeo, F C.; Stieglitz, R D.; Novelli-Fischer, U.; Fetscher, S.; Keul, J. Effects of physical activity on fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999, 85, 2273–2277. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Schwartz, A L. Patterns of exercise and fatigue in physically active cancer survivors. Oncol. Nurs. Forum 1998, 25, 485–491. [PUBMED], [INFOTRIEVE], [CSA]